SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-102025
Filing Date
2023-04-14
Accepted
2023-04-14 16:03:54
Documents
5
Period of Report
2023-05-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d491149ddef14a.htm DEF 14A 385850
2 GRAPHIC g491149g00u03.jpg GRAPHIC 139821
3 GRAPHIC g491149g00u04.jpg GRAPHIC 181619
4 GRAPHIC g491149g17d21.jpg GRAPHIC 27792
5 GRAPHIC g491149g89a99.jpg GRAPHIC 38454
  Complete submission text file 0001193125-23-102025.txt   913737
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39979 | Film No.: 23821105
SIC: 2836 Biological Products, (No Diagnostic Substances)